|
|
||||||||
Scavenging by the Type II IL-1 Decoy Receptor in Human Neutrophils1



* Istituto Ricerche Farmacologiche "Mario Negri", Milan, Italy;
Consorzio MIA Dipartimento di Neuroscienze, Universit degli Studi di Milano, Bicocca, Milan, Italy; and
Centro IDET, Istituto di Patologia Generale, Universit di Milan, Milan Italy.
IL-1 elicits its cellular effects by binding a heterodimeric receptor consisting of IL-1RI and the accessory protein, IL-1RAcPr. In addition, it binds to IL-1RII, which lacking signaling function has been ascribed a decoy role. The fate of the ligand following interaction with the decoy receptor was examined in human polymorphonuclear cells (PMN), which express predominantly (>90%) IL-1RII. Incubation of PMN with IL-1
results in a rapid decrease in cell surface-associated ligand accompanied by a concomitant increase in internalized IL-1 with 5060% of IL-1
located intracellularly within 1 h at 37°C. The use of blocking Abs revealed that IL-1 internalization is mediated exclusively by the decoy receptor. The results of inhibitor analysis demonstrate that internalization requires ATP synthesis and involves clathrin-mediated endocytosis. Following removal of the ligand, the receptor was rapidly re-expressed on the cell surface. Cyclohexamide, a protein synthesis inhibitor, had no effect upon the process, suggesting that the re-expressed receptor was recycled. In addition, human keratinocytes stably transfected with IL-1RII (HaCAT 811) also internalized the IL-1RII with 43% cell surface receptor internalized after 90 min. Immunofluorescence microscopy revealed colocalization of the internalized receptor with wheat germ agglutinin-labeled internalized glycoproteins and early endosome Ag-1, a protein associated with the early endosome compartments, indicative of cellular uptake of IL-1RII by endocytosis. In contrast, little or no internalization was observed in other cells of immune origin. These results suggest that the decoy receptor IL-1RII can act as a scavenger of IL-1, representing a novel autoregulatory mechanism of the IL-1 system.
Related articles in The JI:
This article has been cited by other articles:
![]() |
C. Bellehumeur, J. Blanchet, J.-Y. Fontaine, N. Bourcier, and A. Akoum Interleukin 1 regulates its own receptors in human endometrial cells via distinct mechanisms Hum. Reprod., May 28, 2009; (2009) dep192v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Uriarte, N. R. Jog, G. C. Luerman, S. Bhimani, R. A. Ward, and K. R. McLeish Counterregulation of clathrin-mediated endocytosis by the actin and microtubular cytoskeleton in human neutrophils Am J Physiol Cell Physiol, April 1, 2009; 296(4): C857 - C867. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bujak, M. Dobaczewski, K. Chatila, L. H. Mendoza, N. Li, A. Reddy, and N. G. Frangogiannis Interleukin-1 Receptor Type I Signaling Critically Regulates Infarct Healing and Cardiac Remodeling Am. J. Pathol., July 1, 2008; 173(1): 57 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Glasgow, S. Ramachandran, T. S. Blackwell, T. Mohanakumar, and W. C. Chapman Interleukin-1beta is the primary initiator of pulmonary inflammation following liver injury in mice Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L491 - L496. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Parker, M. K. B. Whyte, S. K. Dower, and I. Sabroe The expression and roles of Toll-like receptors in the biology of the human neutrophil J. Leukoc. Biol., June 1, 2005; 77(6): 886 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Prince, L. Allen, E. C. Jones, P. G. Hellewell, S. K. Dower, M. K.B. Whyte, and I. Sabroe The Role of Interleukin-1{beta} in Direct and Toll-Like Receptor 4-Mediated Neutrophil Activation and Survival Am. J. Pathol., November 1, 2004; 165(5): 1819 - 1826. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mantovani, M. Locati, N. Polentarutti, A. Vecchi, and C. Garlanda Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR J. Leukoc. Biol., May 1, 2004; 75(5): 738 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chon, C. A.J.M. Gaillard, B. B. van der Meijden, H. M. Dijstelbloem, R. J. Kraaijenhagen, D. van Leenen, F. C.P. Holstege, J. A. Joles, H. A.R. Bluyssen, H. A. Koomans, et al. Broadly Altered Gene Expression in Blood Leukocytes in Essential Hypertension Is Absent During Treatment Hypertension, May 1, 2004; 43(5): 947 - 951. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |